Neuroprotection

This article delves into the rapidly growing realm of cannabinoids as potential therapeutic agents in managing COVID-19, engendered by SARS-CoV-2. By navigating through the antiviral and immunomodulatory properties of cannabinoids, the article seeks to provide a nuanced understanding of their potential impact on disease management, while elucidating the pivotal clinical and molecular mechanisms at play. The need for robust clinical trials and further research to corroborate these early insights is emphasized, heralding a call to action for the global scientific community.